News for Wakamoto Pharmaceutical Co.,Ltd. (4512.T)

Published at

Nov 10, 2022 2:00 PM

by seekingalpha.com

positive

positive

Harrow Health: Profitable Ophthalmic Business With Growth Potential (NASDAQ:HROW)

Harrow Health is a well-managed ophthalmic medicines business and has remained profitable for a number of years. Read why HROW stock is a Buy.

HROW 4512.T

Read more →
Published at

Aug 18, 2021 1:00 PM

by thestreet.com

positive

positive

Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.

Harrow Health, Inc. HROW, an ophthalmic‑focused healthcare company, today announced that it has entered into an agreement with Wakamoto Pharmaceutical Co., Ltd.

HROW AMLYY AMLTF 4512.T

Read more →